SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-124102
Filing Date
2022-12-02
Accepted
2022-12-02 16:14:44
Documents
13
Period of Report
2022-12-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2231891d1_8k.htm   iXBRL 8-K 36583
2 EXHIBIT 3.1 tm2231891d1_ex3-1.htm EX-3.1 213599
  Complete submission text file 0001104659-22-124102.txt   471801

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pasg-20221201.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pasg-20221201_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pasg-20221201_pre.xml EX-101.PRE 22599
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2231891d1_8k_htm.xml XML 3853
Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312
Passage BIO, Inc. (Filer) CIK: 0001787297 (see all company filings)

IRS No.: 822729751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39231 | Film No.: 221442099
SIC: 2836 Biological Products, (No Diagnostic Substances)